Published in J Eur Acad Dermatol Venereol on January 01, 2006
Quality of life and psychological morbidity in vitiligo patients: a study in a teaching hospital from north-East India. Indian J Dermatol (2015) 2.03
Simvastatin prevents and reverses depigmentation in a mouse model of vitiligo. J Invest Dermatol (2014) 1.03
Innate immune mechanisms in vitiligo: danger from within. Curr Opin Immunol (2013) 0.97
A systematic review of natural health product treatment for vitiligo. BMC Dermatol (2008) 0.88
Ginkgo biloba for the treatment of vitilgo vulgaris: an open label pilot clinical trial. BMC Complement Altern Med (2011) 0.83
Rapid response of facial vitiligo to 308nm excimer laser and topical calcipotriene. J Clin Aesthet Dermatol (2011) 0.81
Effectiveness of a 308-nm excimer laser in treatment of vitiligo: a review. Lasers Med Sci (2012) 0.78
Relapse after methylprednisolone oral minipulse therapy in childhood vitiligo: a 12-month follow-up study. Indian J Dermatol (2013) 0.78
Quality of life in patients with skin diseases in central Saudi Arabia. Int J Gen Med (2012) 0.78
Quality of life, self-esteem and psychosocial factors in adolescents with acne vulgaris. An Bras Dermatol (2015) 0.78
Efficacy of targeted narrowband ultraviolet B therapy in vitiligo. Indian J Dermatol (2014) 0.76
Dysregulated autophagy increased melanocyte sensitivity to H2O2-induced oxidative stress in vitiligo. Sci Rep (2017) 0.75
Liver X Receptor-α polymorphisms (rs11039155 and rs2279238) are associated with susceptibility to vitiligo. Meta Gene (2016) 0.75
Is Lesional Stability in Vitiligo More Important Than Disease Stability for Performing Surgical Interventions? Results from a Multicentric Study. J Cutan Aesthet Surg (2016) 0.75
Vitiligo blood transcriptomics provides new insights into disease mechanisms and identifies potential novel therapeutic targets. BMC Genomics (2017) 0.75
Interactome analysis of gene expression profile reveals potential novel key transcriptional regulators of skin pathology in vitiligo. Genes Immun (2015) 0.75
SPECT neuropsychological activation procedure with the Verbal Fluency Test in attempted suicide patients. Nucl Med Commun (2002) 1.65
Immune reactions in benign and malignant melanocytic lesions: lessons for immunotherapy. Pigment Cell Melanoma Res (2010) 1.54
Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference. Pigment Cell Melanoma Res (2012) 1.48
Hypochromic vitiligo: delineation of a new entity. Br J Dermatol (2014) 1.42
Rituximab in diffuse cutaneous systemic sclerosis: an open-label clinical and histopathological study. Ann Rheum Dis (2010) 1.34
Guidelines for the management of vitiligo: the European Dermatology Forum consensus. Br J Dermatol (2012) 1.24
Quality of life and stigmatization profile in a cohort of vitiligo patients and effect of the use of camouflage. Dermatology (2005) 1.21
Screening for contact allergy to artificial nails. Contact Dermatitis (2005) 0.89
Repigmentation of leucotrichia in vitiligo with noncultured cellular grafting. Br J Dermatol (2012) 0.84
Intrapatient comparison of 308-nm monochromatic excimer light and localized narrow-band UVB phototherapy in the treatment of vitiligo: a randomized controlled trial. Dermatology (2012) 0.79
Distribution patterns in generalized vitiligo. J Eur Acad Dermatol Venereol (2013) 0.78
Evidence in the treatment of head lice: drowning in a swamp of reviews. Clin Infect Dis (2003) 0.77
Autologous cellular suspensions and sheets in the treatment of achromic disorders: the need for future controlled studies. Dermatology (2001) 0.77
The haptoglobin phenotype influences the risk of cutaneous squamous cell carcinoma in kidney transplant patients. J Eur Acad Dermatol Venereol (2011) 0.76
Incidence of scabies in Belgium. Epidemiol Infect (2007) 0.76
[Vitiligo: nothing new?]. Ann Dermatol Venereol (2003) 0.75